These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
457 related articles for article (PubMed ID: 17197361)
1. Mitotically active leiomyoma of the uterus in a postmenopausal breast cancer patient receiving tamoxifen. Liu IF; Yen YS; Cheng YM; Chou CY Taiwan J Obstet Gynecol; 2006 Jun; 45(2):167-9. PubMed ID: 17197361 [TBL] [Abstract][Full Text] [Related]
2. Co-occurrence of atypical endometriosis, subserous uterine leiomyomata, sactosalpinx, serous cystadenoma and bilateral hemorrhagic corpora lutea in a perimenopausal adipose patient taking tamoxifen (20 mg/day) for invasive lobular breast cancer. Ebert AD; Rosenow G; David M; Mechsner S; Magalov IS; Papadopoulos T Gynecol Obstet Invest; 2008; 66(3):209-13. PubMed ID: 18645252 [TBL] [Abstract][Full Text] [Related]
3. Tamoxifen-induced growth of leiomyomas. A case report. Kang J; Baxi L; Heller D J Reprod Med; 1996 Feb; 41(2):119-20. PubMed ID: 8656411 [TBL] [Abstract][Full Text] [Related]
4. MR imaging appearance of the uterus in postmenopausal women receiving tamoxifen therapy for breast cancer: histopathologic correlation. Ascher SM; Johnson JC; Barnes WA; Bae CJ; Patt RH; Zeman RK Radiology; 1996 Jul; 200(1):105-10. PubMed ID: 8657895 [TBL] [Abstract][Full Text] [Related]
6. Uterine leiomyomata and endometrial proliferation in postmenopausal women treated with the anti-oestrogen tamoxifen. Ugwumadu AH; Harding K Eur J Obstet Gynecol Reprod Biol; 1994 Apr; 54(2):153-6. PubMed ID: 8070603 [TBL] [Abstract][Full Text] [Related]
7. Concurrent tamoxifen-related Müllerian adenofibromas in uterus and ovary. Shi H; Chen X; Lv B; Zhang X Int J Clin Exp Pathol; 2015; 8(11):15381-5. PubMed ID: 26823898 [TBL] [Abstract][Full Text] [Related]
8. [Expansive uterine myoma during tamoxifen therapy. 11 cases]. Le Bouëdec G; de Latour M; Dauplat J Presse Med; 1995 Nov; 24(36):1694-6. PubMed ID: 8545398 [TBL] [Abstract][Full Text] [Related]
9. Abnormalities detected on transvaginal ultrasonography in tamoxifen-treated postmenopausal breast cancer patients may represent endometrial cystic atrophy. McGonigle KF; Shaw SL; Vasilev SA; Odom-Maryon T; Roy S; Simpson JF Am J Obstet Gynecol; 1998 Jun; 178(6):1145-50. PubMed ID: 9662294 [TBL] [Abstract][Full Text] [Related]
10. High-grade endometrial stromal sarcoma after tamoxifen therapy for breast cancer. Sesti F; Patrizi L; Ermini B; Palmieri G; Orlandi A; Piccione E Gynecol Obstet Invest; 2005; 60(2):117-20. PubMed ID: 15920338 [TBL] [Abstract][Full Text] [Related]
11. Aromatase inhibitors and postmenopausal breast cancer patients with tamoxifen-induced endometrial pathology. Morales L; Paridaens R; Timmerman D; Neven P Clin Cancer Res; 2006 Sep; 12(18):5603. PubMed ID: 17000698 [No Abstract] [Full Text] [Related]
12. High frequency of adenomyosis in postmenopausal breast cancer patients treated with tamoxifen. Cohen I; Beyth Y; Shapira J; Tepper R; Fishman A; Cordoba M; Bernheim J; Yigael D; Altaras MM Gynecol Obstet Invest; 1997; 44(3):200-5. PubMed ID: 9359649 [TBL] [Abstract][Full Text] [Related]
13. [Comparative study of the endometrial pathology using flexible ambulatory hysteroscopy of patients treated with Tamoxifen]. Kuzmanov B Akush Ginekol (Sofiia); 2004; 43(3):32-3. PubMed ID: 15341254 [TBL] [Abstract][Full Text] [Related]
14. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy]. Hauth E; Libera H; Kimmig R; Forsting M Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840 [TBL] [Abstract][Full Text] [Related]
15. Adenomyosis in the broad ligament and tamoxifen: report of a case. Chung YP; Lin HH; Sheu BC; Mao TL; Chang DY; Huang SC J Obstet Gynaecol Res; 1997 Feb; 23(1):69-73. PubMed ID: 9094821 [TBL] [Abstract][Full Text] [Related]
16. Carcinoid tumor of the uterine corpus. A case report. González-Bosquet E; González-Bosquet J; García Jiménez A; Gil A; Xercavins J J Reprod Med; 1998 Sep; 43(9):844-6. PubMed ID: 9777628 [TBL] [Abstract][Full Text] [Related]
17. Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology. Gerber B; Krause A; Reimer T; Mylonas I; Makovitzky J; Kundt G; Janni W Clin Cancer Res; 2006 Feb; 12(4):1245-50. PubMed ID: 16489080 [TBL] [Abstract][Full Text] [Related]
18. Carcinosarcoma arising in uterine didelphys after tamoxifen therapy for breast cancer: a case report. Suprasert P; Khunamornpong S J Med Assoc Thai; 2010 May; 93(5):608-12. PubMed ID: 20524448 [TBL] [Abstract][Full Text] [Related]
19. Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study. Achiron R; Lipitz S; Sivan E; Goldenberg M; Horovitz A; Frenkel Y; Mashiach S Ultrasound Obstet Gynecol; 1995 Aug; 6(2):116-20. PubMed ID: 8535913 [TBL] [Abstract][Full Text] [Related]
20. Leiomyoma of the breast in a 50-year-old woman receiving tamoxifen. Son EJ; Oh KK; Kim EK; Son HJ; Jung WH; Lee HD AJR Am J Roentgenol; 1998 Dec; 171(6):1684-6. PubMed ID: 9843313 [No Abstract] [Full Text] [Related] [Next] [New Search]